162 related articles for article (PubMed ID: 26906712)
1. Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes.
Duvnjak L; Blaslov K; Perković MN; Ćuća JK
Endocrine; 2016 Aug; 53(2):453-8. PubMed ID: 26906712
[TBL] [Abstract][Full Text] [Related]
2. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
Blaslov K; Bulum T; Duvnjak L
J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
[TBL] [Abstract][Full Text] [Related]
3. Serum Dipeptidyl peptidase-4 level is related to adiposity in type 1 diabetic adolescents.
Ibrahim A; Salah S; Attia M; Madani H; Ahmad S; Arafa N; Soliman H
Diabetes Metab Syndr; 2020; 14(4):609-614. PubMed ID: 32422444
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Estimated Glucose Disposal Rate Methods for Detecting Insulin Resistance in Adults with Type 1 Diabetes Mellitus.
Canat MM; Altuntaş Y
Metab Syndr Relat Disord; 2024 May; 22(4):295-301. PubMed ID: 38546845
[No Abstract] [Full Text] [Related]
5. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.
Varga T; Somogyi A; Barna G; Wichmann B; Nagy G; Rácz K; Selmeci L; Firneisz G
Pathol Oncol Res; 2011 Dec; 17(4):925-30. PubMed ID: 21785903
[TBL] [Abstract][Full Text] [Related]
6. Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome.
Malin SK; Huang H; Mulya A; Kashyap SR; Kirwan JP
Peptides; 2013 Sep; 47():142-7. PubMed ID: 23872069
[TBL] [Abstract][Full Text] [Related]
7. Fasting serum dipeptidyl peptidase-4 activity is independently associated with alanine aminotransferase in type 1 diabetic patients.
Blaslov K; Bulum T; Knežević-Ćuća J; Duvnjak L
Clin Biochem; 2015 Jan; 48(1-2):39-43. PubMed ID: 25445232
[TBL] [Abstract][Full Text] [Related]
8. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
[TBL] [Abstract][Full Text] [Related]
9. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.
Ryskjaer J; Deacon CF; Carr RD; Krarup T; Madsbad S; Holst J; Vilsbøll T
Eur J Endocrinol; 2006 Sep; 155(3):485-93. PubMed ID: 16914604
[TBL] [Abstract][Full Text] [Related]
10. Persons with latent autoimmune diabetes in adults express higher dipeptidyl peptidase-4 activity compared to persons with type 2 and type 1 diabetes.
Duvnjak L; Blaslov K; Vučić Lovrenčić M; Knežević Ćuća J
Diabetes Res Clin Pract; 2016 Nov; 121():119-126. PubMed ID: 27693949
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance is associated with all chronic complications in type 1 diabetes.
Pop A; Clenciu D; Anghel M; Radu S; Socea B; Mota E; Mota M; Panduru NM;
J Diabetes; 2016 Mar; 8(2):220-8. PubMed ID: 25753338
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 activity is associated with urine albumin excretion in type 1 diabetes.
Duvnjak L; Perković MN; Blaslov K
J Diabetes Complications; 2017 Jan; 31(1):218-222. PubMed ID: 27625045
[TBL] [Abstract][Full Text] [Related]
13. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin.
Helliwell R; Warnes H; Kietsiriroje N; Campbell M; Birch R; Pearson SM; Ajjan RA
Diabet Med; 2021 May; 38(5):e14529. PubMed ID: 33502032
[TBL] [Abstract][Full Text] [Related]
14. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.
Šimonienė D; Platūkiene A; Prakapienė E; Radzevičienė L; Veličkiene D
Diabetes Ther; 2020 Jan; 11(1):161-174. PubMed ID: 31792784
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-4 and adenosine deaminase enzyme levels in polycystic ovary syndrome.
Öztürk B; Gürbüz AS; Durak ZE; Öztürk HS
Gynecol Endocrinol; 2019 Feb; 35(2):138-141. PubMed ID: 30394149
[TBL] [Abstract][Full Text] [Related]
16. DPP-4 inhibitor treatment: β-cell response but not HbA
Kozlovski P; Bhosekar V; Foley JE
Vasc Health Risk Manag; 2017; 13():123-126. PubMed ID: 28408838
[TBL] [Abstract][Full Text] [Related]
17. [Estimated glucose disposal rate in patients under 18 years of age with type 1 diabetes mellitus and overweight or obesity].
Palomo Atance E; Ballester Herrera MJ; Giralt Muiña P; Ruiz Cano R; León Martín A; Giralt Muiña J
Endocrinol Nutr; 2013; 60(7):379-85. PubMed ID: 23731805
[TBL] [Abstract][Full Text] [Related]
18. Does serum cystatin C level reflect insulin resistance in patients with type 1 diabetes?
Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Wegner M; Grzelka A; Wierusz-Wysocka B
Clin Biochem; 2014 Sep; 47(13-14):1235-8. PubMed ID: 24956263
[TBL] [Abstract][Full Text] [Related]
19. The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients.
Fadini GP; Albiero M; Menegazzo L; de Kreutzenberg SV; Avogaro A
Diabetes Obes Metab; 2012 Jun; 14(6):518-22. PubMed ID: 22171692
[TBL] [Abstract][Full Text] [Related]
20. [Elevated serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus: a direct comparison].
Varga T; Firneisz G; Nagy G; Somogyi A
Orv Hetil; 2010 May; 151(22):899-902. PubMed ID: 20478811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
